Price Alert

Zomedica Corp. (ZOM)

AMEX: ZOM · Real-Time Price · USD

0.10

0.00 (2.56%)

At close: Mar 04, 2025, 9:50 AM

Zomedica Statistics

Share Statistics

Zomedica has 979.95M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	979.95M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	30.72%
Shares Floating	961.65M
Failed to Deliver (FTD) Shares	10,014
FTD / Avg. Volume	0.12%

Short Selling Information

Short Interest	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Valuation Ratios

The PE ratio is -5.68 and the forward PE ratio is null. Zomedica's PEG ratio is -0.06.

PE Ratio	-5.68
Forward PE	n/a
PS Ratio	7.79
Forward PS	1.6
PB Ratio	0.82
P/FCF Ratio	-9.51
PEG Ratio	-0.06

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Zomedica.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.06, with a Debt / Equity ratio of 0.01.

Current Ratio	11.06
Quick Ratio	10.49
Debt / Equity	0.01
Debt / EBITDA	-0.09
Debt / FCF	-0.13
Interest Coverage	-180.53

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$174.9K
Profits Per Employee	$-239.78K
Employee Count	144
Asset Turnover	0.1
Inventory Turnover	1.54

Taxes

Income Tax	-1.33M
Effective Tax Rate	3.71%

Stock Price Statistics

The stock price has increased by -23.2% in the last 52 weeks. The beta is 1.16, so Zomedica's price volatility has been higher than the market average.

Beta	1.16
52-Week Price Change	-23.2%
50-Day Moving Average	0.09
200-Day Moving Average	0.12
Relative Strength Index (RSI)	41.48
Average Volume (20 Days)	8,541,418

Income Statement

In the last 12 months, Zomedica had revenue of 25.19M and earned -34.53M in profits. Earnings per share was -0.04.

Revenue	25.19M
Gross Profit	17.32M
Operating Income	-31.59M
Net Income	-34.53M
EBITDA	-29.39M
EBIT	-35.69M
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

The company has 12.95M in cash and 2.73M in debt, giving a net cash position of 10.22M.

Cash & Cash Equivalents	12.95M
Total Debt	2.73M
Net Cash	10.22M
Retained Earnings	-170.93M
Total Assets	214.12M
Working Capital	79.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.97M and capital expenditures -4.65M, giving a free cash flow of -20.62M.

Operating Cash Flow	-15.97M
Capital Expenditures	-4.65M
Free Cash Flow	-20.62M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 68.76%, with operating and profit margins of -125.43% and -137.1%.

Gross Margin	68.76%
Operating Margin	-125.43%
Pretax Margin	-142.38%
Profit Margin	-137.1%
EBITDA Margin	-116.68%
EBIT Margin	-125.43%
FCF Margin	-81.87%

Dividends & Yields

ZOM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ZOM.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	3.31
Piotroski F-Score	3